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Abstract
Background: The aim was to compare effectiveness of group versus individual sessions of
physiotherapy in terms of symptoms, quality of life, and costs, and to investigate the effect of patient
preference on uptake and outcome of treatment.
Methods: A pragmatic, multi-centre randomised controlled trial in five British National Health
Service physiotherapy departments. 174 women with stress and/or urge incontinence were
randomised to receive treatment from a physiotherapist delivered in a group or individual setting
over three weekly sessions. Outcome were measured as Symptom Severity Index; Incontinence-
related Quality of Life questionnaire; National Health Service costs, and out of pocket expenses.
Results: The majority of women expressed no preference (55%) or preference for individual
treatment (36%). Treatment attendance was good, with similar attendance with both service
delivery models. Overall, there were no statistically significant differences in symptom severity or
quality of life outcomes between the models. Over 85% of women reported a subjective benefit of
treatment, with a slightly higher rating in the individual compared with the group setting. When all
health care costs were considered, average cost per patient was lower for group sessions (Mean
cost difference £52.91 95%, confidence interval (£25.82 - £80.00)).
Conclusion: Indications are that whilst some women may have an initial preference for individual
treatment, there are no substantial differences in the symptom, quality of life outcomes or non-
attendance. Because of the significant difference in mean cost, group treatment is recommended.
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Female urinary incontinence (FUI) is a major health prob-
lem and has a significant detrimental impact quality of
life [1]. Feelings of low self-esteem, embarrassment and
helplessness are common[2]. Between 20-50% of women
suffer from incontinence at some time in their lives [3,4],
and the prevalence of symptoms and demand for services
is rising substantially [5]. Pelvic floor exercises delivered
in an individual consultation with a physiotherapist are
effective in the management of stress-related and urge
female urinary incontinence [6-8]. Some physiotherapists
advocate the use of group treatments to deliver these treat-
ments, the hypothetical benefits being increased peer-sup-
port, mutual self-help, giving and sharing of information,
reduction in depression and isolation, increased motiva-
tion and compliance with treatment[9]. A large ran-
domised controlled trial (RCT) from the Netherlands
showed no difference in the physical responses to treat-
ment between individual and group sessions, but did not
consider quality of life, acceptability or cost [10]. If effec-
tiveness can be demonstrated across a range of physical
and health related quality of life outcomes, the group
approach is potentially more cost-effective, provided that
other important components of resource use are not
increased, and women are not deterred from attending
treatment. The aim of this study was to undertake an
appraisal of the acceptability, clinical effectiveness and
relative costs of group versus individual treatment ses-
sions in the management of female urinary incontinence.
The study used a mixed methods approach, integrating
quantitative and qualitative approaches alongside a pro-
spective cost analysis. The qualitative study is reported in
an accompanying paper.
Methods
Aims
To (i) compare effectiveness in terms of symptoms, qual-
ity of life, and costs. (ii) Determine patient preference for
group or individual physiotherapy sessions for the man-
agement of female urinary incontinence and the associa-
tion between patient preference and outcome.
Participants and eligibility
Inclusion criteria were (i) women aged 18 years and over;
(ii) able and willing to give informed written consent with
an interpreter if necessary; (iii) clinical symptoms of stress
and/or urge incontinence. Exclusion criteria were (i) preg-
nancy; (ii) recent pelvic surgery (less than three months);
(iii) history of pelvic malignancy; (iv) current urinary
infection; (v) grade III and IV prolapse; (vi) disease of the
central nervous system (e.g. multiple sclerosis, cerebrovas-
cular accident) or acute mental illness and dementia; (vi)
previous physiotherapy for incontinence within the last
12 months.
Women were recruited from primary and secondary care
referrals made to physiotherapy departments of five
medium to large sized National Health Service (NHS)
trusts in England, UK (detailed at the end of the paper).
The study had the approval of Local Research Ethics Com-
mittees and written consent was obtained from all partic-
ipants.
Outcome measures
Assessments were made prior to treatment (baseline), and
then at 6 weeks and 5 months after randomisation. The
primary outcomes were the Symptom Severity Index
(SSI), with scores ranging from 0 (no severity) to 20 (max-
imum severity) [11] and the Incontinence-related Quality
of Life (IQOL) questionnaire, with scores ranging from 0
(very poor) to 100 (excellent) [12]. The SSI focuses on the
physical symptoms of urinary incontinence, and IQOL
focuses on the psychological and distress aspects of the
condition. Secondary outcomes consisted of health serv-
ice costs incurred in the follow up period, out of pocket
expenses and costs incurred by patients. In addition,
patients were asked to rate their perception of response to
treatment on a 10-point rating of benefit (from no benefit
to maximum benefit). Follow-up data were collected by
postal questionnaire.
Preference
Elicitation of preference was independent of randomisa-
tion, and was collected at the time the women were
invited to participate in the trial. Women were asked, if
they could choose, whether their preference was treatment
in a group setting, on an individual basis or no preference.
Intervention
Group treatment
The treatment comprised three one-hour long sessions
over a three-week period. Group sizes were anticipated to
be approximately 10 women. The first session included an
explanation of normal bladder function, causes of stress
incontinence, teaching and practice of pelvic floor exer-
cises. The second session included causes of urge inconti-
nence, principles of bladder training, discussion and
motivation, practice and progression of pelvic floor exer-
cise including exercises to target fast and slow twitch
fibres, with a variation of starting positions. The third ses-
sion included a bladder quiz to re-enforce knowledge,
avoidance of aggravating factors, repetition of pelvic floor
exercises, discussion and motivation and safe lifting.
Women received an individual assessment prior to the
groups, including a pelvic floor examination if indicated.
Details of the treatment are available at http://www2.war
wick.ac.uk/fac/med/research/ctu/trials/ecr/bladders.Page 2 of 9
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All participants received an assessment using the same
protocol as the group session, followed by any of the tech-
niques used in the group sessions, taught on a one to one
basis. A maximum of three sessions of one-hour duration
was permissible, reflecting the duration of the group ses-
sions. Additional treatments, including electrotherapy,
vaginal cones and biofeedback were not included in either
treatment protocol.
Randomisation and blinding
Randomisation was in a ratio of 2:1 (group: individual) to
facilitate regular group sessions, and minimise waiting for
treatment. Researchers involved with data collection,
entry and analysis, were blind to the treatment delivered
to each participant. It was not possible to blind the partic-
ipants or the clinical collaborators delivering the treat-
ment. The allocation sequence was random (computer
generated). Allocations were coded and transferred to
brown, sealed, sequentially numbered envelopes. The
sequential entry of participants was carefully monitored
during quality control checks.
Statistical analysis
Sample size
The sample size was estimated a priori, assuming a power
of 90% and a significance level of 0.05 to detect a mini-
mally clinically important difference between the groups
of 2 points (standard deviation 3.16) on the SSI scale.
Allowing for a 20% withdrawal and dropout rate, a mini-
mum sample size of a total of 140 patients was
required[13]. No correction was needed for the imbal-
anced randomisation[13].
Statistical and economic analysis
All statistical and economic analyses were intention to
treat and statistical significance was claimed at p < 0.05.
Baseline characteristics were compared for those who
completed the trial and the non-completers. To address
potential biases due to incomplete data, two analyses
were computed (a) complete case analysis (CCA) and (b)
replacing missing observations using multiple imputa-
tion[14], combined to give one inference using the rules
of Little and Rubin [15]. The imputation dataset was used
for sensitivity analysis and produced very similar results to
the complete case analysis. The complete case analysis has
been reported in this paper. The distributions of the data
were checked to ensure parametric assumptions were met.
Continuous and categorical data were summarised as
mean and standard deviation at each time point. Analysis
of covariance was used to assess the treatment effects
adjusted for age, baseline value and preference for treat-
ment at baseline. For categorical data, logistic regression
was used. A simple economic appraisal was conducted
alongside the trial. Cost data were collected by self-com-
pleted questionnaire to determine direct costs (i.e. those
incurred by the patient, NHS or private healthcare system)
and major components of productivity loss (i.e. days of
absence from usual occupation). Healthcare costs
included in and out-patient hospital appointments and
admissions (nurse, consultant or other), visits to the GP,
medicines and pads on prescription, personal expenditure
on medicines, pads, complementary therapies, and other
hygiene products. Unit costs for health care were taken
from Department of Health reference costs which were
available in 2005 [16]. All costs were standardised to the
NHS financial year 2004/2005 which was when the cost-
analysis was completed. Costs of days off work were based
on average wages in 2004. Owing to the relatively short
time frame of the study, discounting was not applied. As
the economic analysis was by intention to treat, the cost
estimates for group treatment includes the costs associ-
ated with providing individual treatments in who were
randomised to group treatment but received individual
treatment. The costs of non-attendance were included in
the analysis using intention to treat principles.
Results
Participant flow and characteristics
The flow of participants through the study (consort state-
ment) is given in Figure 1. Between February 2003 and
March 2004, 174 eligible women were randomised (111
to group and 63 to individual therapy arms) and 91%
(158/174) of women completed the trial. Seven women
(4%), all of who were in the group treatment arm, with-
drew during the trial - either because of illness (n = 5) or
delays in being offered a treatment slot (n = 2). Near equal
numbers of women were lost to follow up in each arm (6/
111 group treatment; 3/63 in individual treatment).
Twenty-eight women in the group therapy sessions
received individual as opposed to group sessions. The pri-
mary reason for this was the timing of the sessions. Partic-
ipant characteristics are shown in Table 1, and were well
matched in the two arms of the trial. There were no statis-
tically or clinically significant differences between women
who completed the trial and those who did not. The
number of non-responders between the five referrals cen-
tres was borderline significant at 6 weeks (p = 0.041).
Treatments received
Five physiotherapists were involved in delivering the
intervention, and gave both individual and group treat-
ments. The median number of treatment sessions was 3 in
both the individual and group treatment arms. The uptake
of treatment was similar across all sites. Adherence with
the clinical protocol was good, with only 4% of women
receiving more than 3 treatment sessions in the group
arm, and 2% in the individual arm (see Figure 2 for treat-
ment attendance). Equal numbers of women did not
attend treatment in each arm (6%). The average group sizePage 3 of 9
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Consort diagramFigure 1
Consort diagram.
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Table 1: Baseline assessments for each treatment arm
Group
(n = 111)
Individual (n = 63)
Age Mean (SD) 49 (10.7) 56 (12.8)
Height Cm (sd) 162.9 (6.61) 161.9 (6.26)
Weight Kg (sd) 75.0 (15.66) 72.2 (14.08)
First language English (%) 109 (98%) 61 (97%)
Other EU (%) 0 (0%) 1 (2%)
Asian (%) 2 (2%) 0 (0%)
Other (%) 0 (0%) 1 (2%)
Health Status/5 Mean (SD) 2.7 (1.07) 2.6 (0.8)
GP appointments in the last year Mean (SD) 1.84 (1.59) 1.56 (1.19)
Education continued after school Yes (%) 61 (55%) 35 (56%)
No (%) 50 (45%) 28 (44%)
Degree or equivalent qualification Yes (%) 36 (32%) 25 (40%)
No (%) 75 (68%) 38 (60%)
Employed Yes (%) 73 (66%) 33 (52%)
No (%) 38 (34%) 30 (48%)
Other limiting illness Yes (%) 36 (32%) 21 (33%)
Years of living with urinary problem Mean (SD) 5.8 (6.44) 6.6 (7.71)
Previous surgical treatment Yes (%) 7 (6%) 7 (11%)
No (%) 103 (93%) 56 (89%)
SSI (0 - 20) Mean (SD) 10.62 (3.96) 10.08 (4.41)
IQOL (0 - 100) Mean (SD) 58.48 (23.01) 61.27 (21.49)
Previous physiotherapy treatment Yes 10 (9%) 7 (11%)
No 101 (91%) 56 (89%)
Preference for treatment prior to study Group 12 (11%) 4 (6%)
Individual 38 (34%) 24 (38%)
No preference 61 (55%) 35 (55%)
BMC Women's Health 2009, 9:26 http://www.biomedcentral.com/1472-6874/9/26was 7, decreasing to 6.4 and 6.3 women at the second and
third groups. Treatments received in either arm were
almost identical with over 90% of group and individual
sessions containing education, advice and pelvic floor
exercises. Bladder re-education was a common compo-
nent of both individual (78%) and group based treat-
ments (70%). Digital examination was used more
frequently in the individual group (9.5% versus 4%).
Efficacy analysis
Disease specific outcomes
The majority of women reported improvements in the SSI
and IQOL over the study period, with no statistically or
clinically significant differences between the arms of the
trial (Additional file 1).
Self-rated assessment of treatment benefit
Women in the individual arm reported greater self-rated
benefit (data shown in Table 2).
Preferences
Just over half of the women (55% in each group)
expressed no preference. Of the remainder, the majority
expressed a preference for individual treatment and these
were near equally allocated to group and individual treat-
ment (Table 1). Preference was associated weakly with
more severe symptoms (measured by the SSI). Women
who expressed a preference for group treatment tended
toward milder symptoms (χ2 = 11.65 p < 0.05). However,
using a formal test of interaction, preference was not asso-
ciated with outcome. Also, preference was not associated
Percentage of women randomised who attended 0, 1, 2, 3, 4 and > 5 sessions by assig mentFigure 2
Percentage of women randomised who attended 0, 
1, 2, 3, 4 and > 5 sessions by assignment.
Table 2: Number (and percentage) of women who gained benefit from treatment (ranging from 0 to 10) for the follow-up time-points
3 months 5 months
Benefit gained from treatment (0-10) Group Individual Group Individual
Missing 15 (13.5%) 8 (12.7%) 12 (10.8%) 3 (4.8%)
0 7 (6.3%) 3 (4.8%) 7 (6.3%) 5 (7.9%)
1 2 (1.8%) 0 (0%) 3 (2.7%) 0 (0%)
2 7 (6.3%) 1 (1.6%) 3 (2.7%) 3 (4.8%)
3 16 (14.4%) 3 (4.8%) 13 (11.7%) 2 (3.2%)
4 9 (8.1%) 5 (7.9%) 7 (6.3%) 3 (4.8%)
5 15 (13.5%) 11 (17.5%) 21 (18.9%) 9 (14.3%)
6 10 (9%) 5 (7.9%) 6 (5.4%) 3 (4.8%)
7 10 (9%) 7 (11.1%) 13 (11.7%) 9 (14.3%)
8 12 (10.8%) 9 (14.3%) 13 (11.7%) 13 (20.6%)
9 2 (1.8%) 1 (1.6%) 6 (5.4%) 6 (9.5%)
10 6 (5.4%) 10 (15.9%) 7 (6.3%) 7 (11.1%)Page 6 of 9
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istics
Cost analysis
Group treatments cost significantly less (Additional file
2). The average cost to the NHS of the treatments provi-
sion was £7.73 per group participant, and £53.37 per par-
ticipant for individual treatment. When all health care
costs were considered (including NHS service costs and
patient costs incurred), the average cost per patient was
£52.91 (£25.82 to £80.00) lower in the group treatment
arm.
Discussion
It is accepted that education, advice, pelvic floor exercises
and bladder re-training are essential and effective in the
management of stress and urge urinary incontinence in
both younger and older women [17-19]. Other treatments
including electrotherapies, biofeedback, vaginal cones
offer no substantial advantage over these
approaches[8,18] and hence were excluded from both the
individual and group treatment arms. By five months
symptoms were reduced and incontinence quality of life
improved, regardless of the treatment allocation.
Responses to treatment in terms of disease specific out-
comes were greater in women allocated to the group ses-
sions, although the difference did not reach statistical
significance. If left unmanaged, symptoms of inconti-
nence would not resolve spontaneously[20].
The burden of incontinence is well recognised at the pop-
ulation level [5]. Demand for incontinence services is
high, and is set to increase substantially due to the combi-
nation of population ageing and more women seeking
treatment [5]. Significant gains in health related quality of
life would occur if effective treatments were both provided
to and used by women with incontinence. Group treat-
ments are attractive from the provider perspective, and
our study confirms that groups are associated with lower
average costs.
Although there was a trend toward greater benefits in
terms of health related quality of life in the group ses-
sions, these did not reach statistical significance. This is
surprising as lowering psychological burden, which is one
of the main components of the IQOL, is one of the postu-
lated mechanisms of group sessions. It is possible that the
format of groups was too didactic, and a more interactive
approach may have been better.
Being embarrassed about symptoms is a barrier to seeking
treatment[21]. Surprisingly, preference for treatments had
little association with treatment effectiveness. One expla-
nation is that only a minority of women expressed a pref-
erence. Further insight may have been gained by
measuring the strength of preference. Women who were
randomised against their preference for individual treat-
ment (i.e. to group treatment) were interviewed to ascer-
tain their concerns and to gain insights into improving the
acceptability of the service delivery model. These findings
are reported in the accompanying manuscript.
Self-rated response to the intervention was somewhat
convergent with the disease specific outcomes. This dis-
crepancy is most likely due to the increased and individu-
alised attention that women receiving one to one
treatments may have perceived. Attendance at the sessions
was similar in both arms of the trial, and further supports
the hypothesis that acceptability was equal.
Strengths and Weaknesses of the Study
Randomised comparisons of different service delivery
models are relatively rare. The sample size was calculated
a priori, without accounting for any potential clustering or
therapist effects. As the loss to follow up rate was smaller
than anticipated, the eventual sample size was 158
patients, giving sufficient power to account for the modest
clustering effects observed. We cannot imply equivalence
of these two approaches; we were not powered to do so,
but can confirm that there was no indication of a substan-
tial and systematic difference between the treatments.
The follow up time period was relatively short, although
similar to several trials of physiotherapy[22]. We cannot
generalise beyond the 5-month follow up period. Future
studies should have longer periods of follow up.
We monitored relative costs using self-reported data using
a postal questionnaire. Whilst it was not possible to col-
lect detailed costs that can be ascertained during face-to-
face interview[23], the use of questionnaires to determine
major costs is recognised as a valid technique [24].
Conclusion
Whilst women or health service providers may have initial
reservations about group treatment, there are no substan-
tial differences in the symptom, psychological, or quality
of life outcomes. Attendance was very similar between the
two arms, allying fears that the groups might intimidate
women, and result in non-attendance. Acceptability was
explored further to determine how implementation of
group treatments might be improved, and is presented in
the accompanying paper.
Findings are consistent with our knowledge of the physi-
cal effects of physiotherapy for treatment for urinary
incontinence[22]. This is the first trial to investigate the
claim group treatments may have a psychological effect.
The group sessions were no more effective in reducing thePage 7 of 9
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vidual sessions.
Urinary incontinence is a significant public health prob-
lem, and group treatments offer one method of offering
treatment to large groups of patients. Commissioners and
policy makers should feel confident that women will both
attend and gain benefit from group sessions.
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